Pałka, A.; Gajda, M.; Kapczyński, N.; Jachowicz-Matczak, E.; Krzanowski, M.; Kasprzyk, J.; Żółtowska, B.; Czepiel, J.; Wójkowska-Mach, J.
Oral Vancomycin in the Treatment of Clostridioides difficile Infection: A Single-Center Observational Study in Southern Poland (2016–2022), Involving 528,887 Hospitalized Patients. Antibiotics 2026, 15, 161.
https://doi.org/10.3390/antibiotics15020161
AMA Style
Pałka A, Gajda M, Kapczyński N, Jachowicz-Matczak E, Krzanowski M, Kasprzyk J, Żółtowska B, Czepiel J, Wójkowska-Mach J.
Oral Vancomycin in the Treatment of Clostridioides difficile Infection: A Single-Center Observational Study in Southern Poland (2016–2022), Involving 528,887 Hospitalized Patients. Antibiotics. 2026; 15(2):161.
https://doi.org/10.3390/antibiotics15020161
Chicago/Turabian Style
Pałka, Anna, Mateusz Gajda, Norbert Kapczyński, Estera Jachowicz-Matczak, Marcin Krzanowski, Jakub Kasprzyk, Barbara Żółtowska, Jacek Czepiel, and Jadwiga Wójkowska-Mach.
2026. "Oral Vancomycin in the Treatment of Clostridioides difficile Infection: A Single-Center Observational Study in Southern Poland (2016–2022), Involving 528,887 Hospitalized Patients" Antibiotics 15, no. 2: 161.
https://doi.org/10.3390/antibiotics15020161
APA Style
Pałka, A., Gajda, M., Kapczyński, N., Jachowicz-Matczak, E., Krzanowski, M., Kasprzyk, J., Żółtowska, B., Czepiel, J., & Wójkowska-Mach, J.
(2026). Oral Vancomycin in the Treatment of Clostridioides difficile Infection: A Single-Center Observational Study in Southern Poland (2016–2022), Involving 528,887 Hospitalized Patients. Antibiotics, 15(2), 161.
https://doi.org/10.3390/antibiotics15020161
